Skip to content
10-Q

Quarterly Report

HI TECH PHARMACAL CO INC

0001193125-13-361533

← back to feed
Filed
Sep 9, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Sep 5, 2013 13.62M sh
Shares Diluted Q1 2014 · Jul 31, 2013 13.75M sh
Shares Diluted Q1 2014 · Jul 31, 2012 13.55M sh
Capex Q1 2014 · Jul 31, 2013 $3.67M
Capex Q1 2014 · Jul 31, 2012 $1.21M
Long Term Debt Q1 2014 · Jul 31, 2013 $799K
Long Term Debt Q1 2014 · Apr 30, 2013 $888K
Short Term Debt Q1 2014 · Jul 31, 2013 $355K
Short Term Debt Q1 2014 · Apr 30, 2013 $355K
Cash And Equivalents Q1 2014 · Jul 31, 2013 $108.28M
Cash And Equivalents Q1 2014 · Apr 30, 2013 $100.61M
Cash And Equivalents Q1 2014 · Jul 31, 2012 $92.25M
Cash And Equivalents Q1 2014 · Apr 30, 2012 $87.55M
Stockholders Equity Q1 2014 · Jul 31, 2013 $251.67M
Stockholders Equity Q1 2014 · Apr 30, 2013 $245.37M
Current Liabilities Q1 2014 · Jul 31, 2013 $50.93M
Current Liabilities Q1 2014 · Apr 30, 2013 $43.9M
Total Liabilities Q1 2014 · Jul 31, 2013 $55.95M
Total Liabilities Q1 2014 · Apr 30, 2013 $49.63M
Current Assets Q1 2014 · Jul 31, 2013 $229.54M
Current Assets Q1 2014 · Apr 30, 2013 $219.56M
Total Assets Q1 2014 · Jul 31, 2013 $307.62M
Total Assets Q1 2014 · Apr 30, 2013 $295M
Eps Diluted Q1 2014 · Jul 31, 2013 $0.33
Eps Diluted Q1 2014 · Jul 31, 2012 $0.44
Eps Basic Q1 2014 · Jul 31, 2013 $0.34
Eps Basic Q1 2014 · Jul 31, 2012 $0.46
Sga Expense Q1 2014 · Jul 31, 2013 $12.94M
Sga Expense Q1 2014 · Jul 31, 2012 $10.63M
Rd Expense Q1 2014 · Jul 31, 2013 $3.96M
Rd Expense Q1 2014 · Jul 31, 2012 $4.47M
Net Income Q1 2014 · Jul 31, 2013 $4.55M
Net Income Q1 2014 · Jul 31, 2012 $6M
Gross Profit Q1 2014 · Jul 31, 2013 $25.43M
Gross Profit Q1 2014 · Jul 31, 2012 $25.32M
Cost Of Revenue Q1 2014 · Jul 31, 2013 $25.08M
Cost Of Revenue Q1 2014 · Jul 31, 2012 $26.72M
Revenue Q1 2014 · Jul 31, 2013 $50.5M
Revenue Q1 2014 · Jul 31, 2012 $52.04M
Dividends Paid Q1 2014 · Dec 31, 2012 $20.18M